Polycystic Ovary Syndrome News

Women with polycystic ovary syndrome gained more weight annually than those without PCOS, and some lifestyle factors had a greater impact on weight gain with PCOS, according to study data.

Taste sensation, particularly taste for salty and sour, is reduced among women with polycystic ovary syndrome compared with healthy controls, with the differences persisting after short-term oral contraceptive use, data show.

Social determinants of health play a role in whether women receive a diagnosis of polycystic ovary syndrome, according to a case control study presented at the ASRM Scientific Congress & Expo.

Most primary care providers who were surveyed said they use an HbA1C test to screen patients with polycystic ovary syndrome for diabetes, a practice which runs contrary to several society guidelines, according to researchers.

The overall economic burden of treating polycystic ovary syndrome in the U.S. exceeds $7.9 billion annually, with almost half the cost attributed to treating the direct costs of stroke and type 2 diabetes.

Women with polycystic ovary syndrome who take probiotics and synbiotics may see some “partially beneficial effect” on indices of insulin resistance, according to a meta-analysis published in the Journal of International Medical Research.

An analysis of polycystic ovary syndrome symptoms using a menstrual tracking app shows common traits of the disorder may be broader than Rotterdam criteria symptoms, according to data published in Reproductive Biology and Endocrinology.

Genetic risk factors for polycystic ovary syndrome can act independently of ovarian function, causing cardiometabolic dysfunction and hyperandrogenism through biological pathways common to both men and women, according to a speaker.

Neuroendocrine, reproductive and metabolic dysfunctions associated with polycystic ovary syndrome are transmitted in mice exposed prenatally to anti-Müllerian hormone for at least three generations, new data show.

Polycystic ovary syndrome is a lifelong endocrine, metabolic and reproductive disorder estimated to affect 5% to 15% of women in the United States, depending on how the condition is characterized.